









Markets
/
Stocks
/
nasdaq-infu
/

InfuSystem Holdings Inc

INFU

10.290USD

+0.290+2.90%

Close 11/06, 16:00（ET）Quotes delayed by 15 min

209.17MMarket Cap

37.87P/E TTM



InfuSystem Holdings Inc

10.290

+0.290+2.90%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of InfuSystem Holdings Inc

Currency: USD Updated: 2025-11-06

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing well in the stock market, with strong fundamentals and technicals supporting the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

InfuSystem Holdings Inc's Score

Industry at a Glance

Industry Ranking

44 / 210

Overall Ranking

119 / 4615

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 5 analysts

Buy

Current Rating

14.200

Target Price

+42.00%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

InfuSystem Holdings Inc Highlights

StrengthsRisks

InfuSystem Holdings, Inc. is a national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 22.70% year-on-year.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 134.86M.

Undervalued

The company’s latest PE is 38.86, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 15.31M shares, decreasing 13.63% quarter-over-quarter.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 2.54.

Financial Health

Currency: USD Updated: 2025-11-06

The company's current financial score is 7.83, which is higher than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 36.49M, representing a year-over-year increase of 3.31%, while its net profit experienced a year-over-year increase of 25.01%.

Score

Industry at a Glance

Previous score

7.83

Change



Financials

5.97

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

9.24

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

8.70

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

7.88

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.35

Key Metrics

Free cash flow

No Data

InfuSystem Holdings Inc's Company Valuation

Currency: USD Updated: 2025-11-06

The company’s current valuation score is 7.15, which is lower than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is 38.86, which is 31756.59% below the recent high of 12379.31 and 42.00% above the recent low of 22.54.

Score

Industry at a Glance

Previous score

7.15

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 44/210

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-06

The company’s current earnings forecast score is 8.40, which is higher than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for InfuSystem Holdings Inc is 15.00, with a high of 15.00 and a low of 12.00.

Score

Industry at a Glance

Previous score

8.40

Change

Support & Resistance

No Data

Analyst Rating

Based on 5 analysts

Buy

Current Rating

14.200

Target Price

+42.00%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

110

Total

Median

Average

Company name

Ratings

Analysts

InfuSystem Holdings Inc

INFU

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

Dexcom Inc

DXCM

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-06

The company’s current price momentum score is 9.04, which is higher than the Healthcare Equipment & Supplies industry's average of 6.74. Sideways: Currently, the stock price is trading between the resistance level at 11.25 and the support level at 8.95, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

8.81

Change

0.23

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(3)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

0.039

Buy

RSI(14)

54.415

Neutral

STOCH(KDJ)(9,3,3)

65.651

Neutral

ATR(14)

0.647

Low Volatility

CCI(14)

32.923

Neutral

Williams %R

25.214

Buy

TRIX(12,20)

0.112

Sell

StochRSI(14)

77.284

Buy

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

10.102

Buy

MA10

10.162

Buy

MA20

9.807

Buy

MA50

10.073

Buy

MA100

8.545

Buy

MA200

7.376

Buy

Institutional Confidence

Currency: USD Updated: 2025-11-06

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

AWM Investment Company, Inc.

1.27M

-21.77%

Acuitas Investments LLC

1.03M

-16.01%

Minerva Advisors LLC

994.78K

+9.24%

The Vanguard Group, Inc.

Star Investors

957.64K

-11.35%

Sansone Advisors, LLC

939.29K

-17.84%

First Eagle Investment Management, L.L.C.

Star Investors

910.37K

-1.09%

Punch & Associates Investment Management, Inc.

878.50K

+42.93%

Meros Investment Management, LP

706.50K

+14.69%

Dimensional Fund Advisors, L.P.

564.81K

+10.19%

Dilorio (Richard)

485.99K

+4.61%

Risk Assessment

Currency: USD Updated: 2025-11-06

The company’s current risk assessment score is 3.92, which is lower than the Healthcare Equipment & Supplies industry's average of 4.57. The company's beta value is 1.70. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.